Drug Treatment for Tuberculosis during Pregnancy

@article{Bothamley2001DrugTF,
  title={Drug Treatment for Tuberculosis during Pregnancy},
  author={Graham H Bothamley},
  journal={Drug Safety},
  year={2001},
  volume={24},
  pages={553-565}
}
Untreated tuberculosis in pregnancy poses a significant threat to the mother, fetus and family. Adherence to treatment is especially difficult in pregnancy because of the general fear of any medication and pregnancy-related nausea. Supervised treatment is especially helpful in encouraging adherence.All 4 first line drugs [isoniazid, rifampicin (rifampin), ethambutol and pyrazinamide] have an excellent safety record in pregnancy and are not associated with human fetal malformations. Drug-induced… Expand
Tuberculosis in Pregnancy: A Review
TLDR
The disease is a significant contributor to maternal mortality and is among the three leading causes of death among women aged 15–45 years in high burden areas and the exact incidence of tuberculosis in pregnancy is expected to be as high as in the general population. Expand
Tuberculosis (TB) in pregnancy - A review.
TLDR
Optimum antenatal care and nutrition therapy along with anti-tuberculosis drugs provide for optimum maternal and perinatal outcome. Expand
Tuberculosis and Pregnancy: An Updated Systematic Review
TLDR
The increasing incidence of drug-resistant TB, especially in Eastern Europe and Central Asia, requires an evaluation of the safety of second-line drugs in pregnancy, and the IGRA responses appear to change during pregnancy, with more positive responses after delivery. Expand
Management of TB during pregnancy, especially in high-risk communities
Tuberculosis is a common illness in the world, especially in sub-Saharan Africa, the Indian subcontinent, the former Soviet Union states and China. In western Europe and North America, TB remainsExpand
Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases.
  • Sonya S. Shin, D. Guerra, +9 authors J. Furin
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2003
TLDR
Under certain circumstances, MDR-TB can be successfully treated during pregnancy and, in each of these 7 cases, excellent treatment outcomes were obtained for the women and their children. Expand
Tuberculosis in pregnancy
TLDR
Treatment of non-multi-drug resistance (MDR) patients should be treated by the same regimen as nonpregnant patients except the use of Streptomycin, and so expected mother with MDR-TB should be advised to terminate the pregnancy. Expand
Spanish Society for Pediatric Infectious Diseases guidelines on tuberculosis in pregnant women and neonates (ii): Prophylaxis and treatment ☆
Abstract In pregnant women who have been exposed to tuberculosis (TB), primary isoniazid prophylaxis is only recommended in cases of immunosuppression, chronic medical conditions or obstetric riskExpand
[Spanish Society for Pediatric Infectious Diseases guidelines on tuberculosis in pregnant women and neonates (ii): Prophylaxis and treatment].
In pregnant women who have been exposed to tuberculosis (TB), primary isoniazid prophylaxis is only recommended in cases of immunosuppression, chronic medical conditions or obstetric risk factors,Expand
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials
TLDR
Among reported pregnancies in these two latent tuberculosis infection trials, there was no unexpected fetal loss or congenital anomalies and these data offer some preliminary reassurance to clinicians and patients in circumstances when these drugs and regimens are the best option in pregnancy or in women of child‐bearing potential. Expand
Increased risk of hepatotoxicity and temporary drug withdrawal during treatment of active tuberculosis in pregnant women.
TLDR
Careful monitoring of liver transaminases while receiving TB treatment during pregnancy is mandatory, as well as ensuring adequate measures with adjustment of drug regimen and temporary drug withdrawals when a rise in liver enzymes is noted. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 97 REFERENCES
The maternal and fetal effects of tuberculosis therapy.
TLDR
Therapy should be started as soon as the diagnosis of tuberculosis is confirmed or when suspected in the HIV-infected woman or after the first trimester in women younger than 35-years-old with recent TB tine test conversion. Expand
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
TLDR
Treatment of Tuberculosis should be individualized and based on susceptibility studies, except for children who have miliary tuberculosis, bone/joint tuberculosis, or tuberculous meningitis who should receive a minimum of 12 mo of therapy. Expand
Anti-tuberculosis medication and the liver: dangers and recommendations in management.
TLDR
A protocol for using liver function tests to monitor for liver damage, and recommendations on what action to take when these become abnormal are given. Expand
Tuberculosis in association with pregnancy.
TLDR
Patients with tuberculosis associated with pregnancy have the same clinical presentation as nonpregnant patients, and the drugs that appear to be safest for the fetus include isoniazid, para-aminosalicylic acid, ethambutol, and rifampin. Expand
A prospective controlled multicentre study of clarithromycin in pregnancy.
TLDR
This first prospective controlled study of exposure to clarithromycin in pregnancy suggests that this agent does not increase the rate of major malformations above the baseline risk of 1-3%, but the higher rate of reported spontaneous abortions may warrant further study. Expand
Congenital Defects among Children Born to Women under Supervision or Treatment for Pulmonary Tuberculosis
  • C. Lowe
  • Medicine
  • British journal of preventive & social medicine
  • 1964
TLDR
The results of a survey published by McDonald (1961) suggest that children born to women with pulmonary tuberculosis may show an excess of serious congenital malformations and there is an additional reason for concern in that laboratory experiments suggest that streptomycin is teratogenic for rats. Expand
Isoniazid hepatitis among pregnant and postpartum Hispanic patients.
TLDR
Concerns are raised that deviations from existing policy may contribute to unnecessary morbidity and mortality among patients attending an Hispanic prenatal clinic treated with isoniazid (INH) during and after pregnancy to prevent tuberculosis (TB). Expand
Pregnancy Outcome Following Gestational Exposure to Fluoroquinolones: a Multicenter Prospective Controlled Study
TLDR
It is concluded that the use of fluoroquinolones during embryogenesis is not associated with an increased risk of major malformations and the higher rate of therapeutic abortions observed in quinolone-exposed women compared to that for their controls may be secondary to the misperception of a major risk related to quinoline use during pregnancy. Expand
Obstetrical outcomes among women with extrapulmonary tuberculosis.
TLDR
Extrapulmonary tuberculosis that is confined to the lymph nodes has no effect on obstetrical outcomes, but tuberculosis at other extrapulmonary sites does adversely affect the outcome of pregnancy. Expand
Adverse Reactions to Daily and Intermittent Rifampicin Regimens for Pulmonary Tuberculosis in Hong Kong*
This paper reports the nature, incidence, and severity of adverse reactions to regimens of rifampicin and ethambutol given once weekly, twice weekly, or daily and to a standard reserve regimen in aExpand
...
1
2
3
4
5
...